Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
113 Cards in this Set
- Front
- Back
HPV infects what body parts?
|
the lower genital tract
-vulva -vaginal canal -cervix |
|
condyloma
|
-commonly due to HPV types 6 or 11
|
|
HPV infections have what histological look?
|
Koilocytic change = the nucleus crinkled like a raisen
|
|
how are the risks of HPV classified?
|
high and low risks based on DNA sequencing = risk is how likely to develop carcinoma
LR = 6, 11 HR = 16, 18, 31, 33 (16, 18 MOST common) |
|
common pathology for HPV LR and HR
|
LR (6,11) = Condyloma (warty neoplasm of vulvar skin)
HR(16,18) = dysplasia --> Carcinoma |
|
Condyloma?
|
warty neoplasm of vulvar skin
-HPV 6 or 11 -Low risk to progress to carcinoma |
|
carcinomas stain + for what?
|
keratin +
|
|
lower 2/3 of vagina derives from?
in development Upper 1/3 derives from? histology of each part? (type of tissue) what happens during development? |
lower 2/3 (squamous) = Urogenital sinus (UGS)
upper 1/3 (columnar cells) = mullerian duct -lower squamous cells take over columnar cells and replace them completely |
|
adenosis?
|
persistance of columnar epithelium in upper 1/3 of vagina
-inc incidence in females exposed to DES in utero -inc risk for clear cell adenocarcinoma |
|
Vaginal carcinoma
-arises from? -etiology |
carcinoma arising form squamous epithelium lining the vaginal mucosa
-related to high-risk HPV -precursor lesion is Vaginal Intraepithelial Neoplasia (VIN) |
|
Clear cell adenocarcinoma
|
malignant proliferation of glands with clear cytoplasm
-due to DES associated vaginal adenosis |
|
Embryonal rhabdomyosarcoma
-origin |
malignant mesenchymal proliferation of immature skeletal muscle
(rare) |
|
Embryonal rhabdomyosarcoma
-presentation |
bleeding grape-like mass protruding from vagina or penis is child (<5)
|
|
lower 2/3 of vagina derives from?
|
urogenital sinus
|
|
upper 1/3 of vagina derives from?
|
mullerian duct (but then is replaced by ?)
|
|
cancer from lower 2/3 of vagina goes to what lymph nodes?
|
inguinal lymph nodes
|
|
cancer from upper 1/3 of vagina goes to what lymph nodes?
|
iliac lymph nodes
|
|
Squamous hyper plasia -lichen simplex chronicus?
-etiology |
-hyperplasia of vulvar squamous epithelium
-leukoplakia with thickening of the vulvar skin (leather like) -benign -opposite of lichen sclerosis |
|
lichen sclerosis
-presentation |
thinning of epidermis (parchment-like = paper-like skin) and fibrosis of dermis
leukoplakia- white plaques on skin -normally benign |
|
common infections of female reproductive path (3) and the organism that causes it
|
Herpes virus (HSV-2) = vulvar cancers
Molluscum contagiosum = molluscum lesions HPV = genital warts, cervical dysplasia |
|
HPV causes?
|
genital warts, cervical dysplasia
|
|
Molluscum contagiosum causes?
|
molluscum lesions
|
|
Herpes virus (HSV-2) causes?
|
= vulvar cancers
|
|
Squamous hyperplasia
-presentation |
-plaques
-hyperkeratosis -thickened epithelium -chronic inflammation slight inc risk for squamous cancer |
|
Condyloma acuminatum
-etiology |
venereal warts (benign tumors)
-HPV-induced (types 6 and 11) -Koilocytes (raisen) -perinuclear clearing |
|
vulvar tumors?
|
Condyloma
|
|
Extra-mammary Paget’s disease
|
Labial red crusted lesions
-Similar to disease in breast |
|
melanoma of vulva
|
Similar to melanomas elsewhere, S100+
-older women |
|
Melanoma
|
Melanoma is a malignant tumor of melanocytes.[2] Melanocytes are cells that produce the dark pigment, melanin,
|
|
vaginal squamous cell carcinoma
-etiology -risks |
malignant neoplasm
-HPV associated -previous cervical cancer |
|
vaginal adenocarcinoma
-etiology -risks -histology |
-DES treated in utero
Risk = vaginal adenosis -Clear cell adenocarcinoma |
|
Embryonal rhabomysarcoma
-Clinical features -Morphology |
Infants and children <5 yoa
-polypoid bulging mass, protrudes from orifice |
|
list the vaginal malignant neoplasms-
|
-squamous cell carcinoma
-adenocarcinoma -embryonal rhabomysarcoma |
|
cervix tissue demaracated into?
-what type of tissue is each -name of area where it changes? |
exocervix - non-keratinized stratified squamous epithelial
endocervix - columnar epithelial -Transformation zone |
|
most common region HPV infects?
|
transformation zone, most common of all the lower genital tract (uterus, cervix, vagina)
|
|
CIN?
|
cervical intraepithelial neoplasia
|
|
when does HPV infection lead to CIN risk?
|
persistant infection leads to inc. risk for cervical intra-epithelial infection (CIN)
(90% of time infection is cleared by immune system) |
|
Risks of CIN depend on?
|
HPV tpyes
16, 18 = HR 6, 11 = LR |
|
HR HPV...what makes them high risk?
|
HR HPV (16, 18) makes E6 & E7 protein
E6- destroys p53 E7- destroys Rb |
|
p53 can?
|
-inhibit dna synthesis and allow DNA repair
or -if there is too much DNA damage, activate Bax and cause apoptosis |
|
CIN
-characterization - |
-Koilocytic change
-nuclear atypic -inc mitosis |
|
gradation of CIN
-based on |
based on number of cells showing dysplasia
I, II, III, CIS (Carcinoma in situ) higher grade means more dysplasia seen in the stratified squamous epithelia |
|
gradation of CIN
-prognosis |
I & II are reversible 66% and 33% respectively (III rarely reverses)
III & CIS, carcinomas will become malignant, and become a "invasive squamous cell carcinoma" |
|
what is the difference between dysplasia and carcinoma (in context of the CIN gradation)
|
dysplasia can reverse, but carcinomas are unable to reverse differentiation
|
|
steps in CIN progression
|
CIN I --> CIN II --> CIN III => CIS --> invasive cervical carcinoma
(may regress) |
|
Cervical carcinoma
-define -onset? |
end malignant stage of CIN progression (invasive cervical carcinoma)
-onset is usually 40-50, takes time 25-30 yrs after HPV virus infection for progression through the CIN stages |
|
what is the difference between CIS and cervical carcinoma
|
CIS is NOT invasive
-cervical carcinoma is invasive, it can be called invasive cervical carcinoma |
|
Cervical carcinoma
-presents as? |
vaginal bleeding
|
|
important risk factors for cervical carcinoma?
|
1) HR HPV (16,18)
2) smoking 3) immunodeficiency |
|
common subtypes of cervical carcinoma?
|
1) squamous cell
2) adenocarcinoma (both are HPV related) |
|
goal of cervical screening?
-golden standard? -effective in detecting? |
catch dysplasia before it develops into carcinoma
-pap smear, only effective for detecting the squamous cell subtype NOT the adenocarcinoma arising from the endocervix |
|
what does the HPV vaccine cover against?
|
Quadrivalent, HPV subtypes 6,11, 16, 18
(only protects for 5 years) |
|
ectocervix
-histo |
non-keratinizing squamous mucosa
in continuity with vaginal mucosa) |
|
transformation zone
|
zone squamo-columnar junction
|
|
endocervix
-histo |
single layer of mucous-secreting columnar epithelium with invaginating glands (this is why it gives rise to adenomas)
|
|
endometrium
|
complex glandular mucosa, hormonally-regulate
|
|
myometrium
|
thick smooth muscle wall
|
|
Cyst
|
an epithelial lined sac, containing fluid or mucus
|
|
Cervical neoplasia
-risk factors |
Early age at first intercourse
MULTIPLE SEXUAL PARTNERS Male partner with multiple previous sex partners (HPV) |
|
Cervical neoplasia
-length of progression - How screened? -How Dx |
Slow progression (up to 20 yrs), not all lesions progress to cancer
- PAP smears detect pre-Ca and cancer (a screening tool) - BX is required for DX |
|
what type of nucleotides does HPV have?
|
DNA
|
|
HPV
-common symptoms? |
common skin warts to condylomas to invasive cancers
|
|
LGSIL (LSIL) HGSIL vs. CIN 1/2
|
- Low Grade Squamous Intraepitheliel Lesion
-grades used for pap smear CIN1,2,3 is for biopsies |
|
what happens to the cells of the cervical epithelium when neoplasia/dysplasia occurs/worsens?
|
The nucleus shrivels (koilocyte), the nucleus becomes large
-the density of cells inc. |
|
Glandular neoplasms of the cervix?
|
Adenocarcinoma in situ (AIS) --> Invasive adenocarcinoma-
major morphologic subtypes endocervical* |
|
growth of endometrium is dependent on?
shedding of the endometrium lining depends on? |
estrogen
-removal of progesterone (this maintains the endometrium) |
|
estrogen and progesterone, cause which phases of the endometrium?
|
estrogen = proliferative (grows)
progesterone = secretory (prepares for implantation) |
|
asherman syndrome
-symptoms -pathophys -etiology |
-secondary amenorrhrea due to loss of the basalis (regenerative layer of the endometrium)
-due to overaggressive Dilation and curettage (D&C) procedure |
|
Curettage
|
is the use of a curette (French, meaning scoop[1]) to remove tissue by scraping or scooping
|
|
Anovulatory cycle
-pathophys |
presence of estrogen proliferative phase without progesterone driven secretory phase
-Thus there is endometriual growth without removal of progesterone and thus no endometrial wall shedding each cycle, and every cycle the endometrium grows, leading to abnormal blood vessel development |
|
Acute endometritis
-symptoms -etiology |
fever, abnormal uterine bleeding, pelvic pain
-caused by bacterial infection of endometrium -usually due to retained products of conception |
|
Chronic endometritis
-histo -causes |
chronic inflammation of endometrium
-characterized by plasma cells -caused by retained products of conception, chronic PID (from STD), IUD |
|
endometrial polyps
|
-hyperplastic protrustion of endometrium
-present as abnormal uterine bleeding -can arise by side effects of tamoxifen ( antagonist of estrogen receptor at breast, but agonist in endometrium) |
|
PID
|
Pelvic inflammatory disease
(can lead to chronic endometritis) |
|
Inflammations of endometrium?
|
acute and chronic endometritis
|
|
Chronic endometritis
-hisopath? -cause? |
PMN’s, lymphs and plasma cells
- Chronic PID Retained elements of pregnancy Intrauterine devices (IUD) |
|
order of progression of histological cellular features of endometrium
|
-proliferative
-secretory -predecidual -PMN -Menses |
|
2 broad categories of dysfunctional uterine bleeding?
|
1) hormonally associate (progesterone/secretory phase)
2) other = fibroids and endometrial/endocervical polyps |
|
Anovulatory cycles
|
Most common
Prolonged estrogen phase Hyperplasia and breakdown |
|
main causes of dysfunctional uterine bleeding
|
-Anovulatory cycles
-Inadequate luteal phase -Oral contraceptives -Menopause |
|
Inadequate luteal phase
|
-Inadequate progesterone
-Infertility |
|
Acute endometritis:
-caused by? |
Miscarriage or post-partum
|
|
Endometriosis
-define |
-abnormal placement of endometrial glands and stroma outside the uterine endometrial lining
|
|
Endometriosis
-symptoms -pathophys |
-dysmenorrhea (pain during menstruation), pelvic pain, infertility
-b/c abnormally place endometrial glands will also cycle during the menstrual cycle |
|
Endometriosis
-cause? |
1) Regurgitation -retrograde menstruation theory- (most popular)
2) metaplastic -endometrial metaplasia (differentiation from precursor tissue) 3) vascular/ lymphatics spread (lungs) |
|
what are the characteristics of endometriosis?
|
hemorrhagic (chocolate) cysts (usually ovary)
-Stroma with “decidual” change and hemosiderin |
|
common sites of endometriosis occurrence?
|
“Seeding pattern” (descending order)
Ovaries (chocolate cyst)> uterine ligaments > rectovaginal segment > peritoneum > abdominal scars > umbilicus etc |
|
endometrial hyperplasia
-etiology |
**Prolonged estrogen stimulation**
-decreased progesterone- i.e., hormonal imbalance -Menopause, tumors, hormone replacement therapy |
|
endometrial hyperplasia
-histology changes? |
-more glands (circles)
low grade - architectural changes (simple & complex) High grade - architectural changes with cellular atypia |
|
what causes endometrial hyperplasia?
-how does it normally present |
-too much unopposed estrogen
-postmenopausal uterine bleeding (they have lost progesterone --> no shedding) and they have estrogen still released not from ovaries but from adipocytes (aromatase) likely in a obese patient |
|
most important predictor for progression to carcinoma is?
|
Cellular atypia
|
|
Most common invasive gynecologic tumor?
|
Endometrial carcinoma
|
|
Endometrial carcinoma
-etiology? |
Prolonged estrogen stimulation and hyperplasia
(endometrial hyperplasia --> carcinoma) |
|
Endometrial carcinoma
-gross |
-Local polypoid mass or involving entire endometrial surface
|
|
Endometrial carcinoma
-histopath |
Adenocarcinomas (85%)
Stratified columnar epithelium (normal is simple columnar) |
|
two pathways (types) to develop endometrial carcinoma?
|
1) hyperplastic pathway leading to endometriod type
2) sporadic pathway leading to serous type |
|
endometriod endometrial carcinoma
-histopath |
Adenocarcinomas
-Stratified columnar epithelium |
|
Endometrial carcinoma, serous type
-histopath |
-serous looking
High grade with complex papillary features--> can form psamomma bodies -Marked nuclear atypia hypechromasia atypical mitoses prominent nucleoli |
|
Endometrial carcinoma, serous type
-associations? |
p53 mutations drives this pathway (early event)
|
|
psamoma bodies?
|
arise from concentric layers of calcification, from death of papillae that necrose and calcify
|
|
key differences of Leiomyoma vs Leiomyosarcoma
|
Leiomyoma = multiple masses
Leiomyosarcoma = single mass = has necrosis = seen in postmenopause (70-80 age) -----> Leiomyoma does NOT become Leiomyosarcoma |
|
does Leiomyoma become Leiomyosarcoma?
|
NO NO NO
|
|
Leiomyosarcoma
-define -etiology -presentation -histo |
malignant proliferation of smooth muscle from myometrium
-arises de novo -seen in postmenopausal women -single lesion with necrosis/hemorrhage -necrosis, mitotic activity, cellular atypia |
|
Leiomyosarcoma
-histo |
necrosis/hemorrhage
-necrosis, mitotic activity, cellular atypia |
|
Leiomyosarcoma vs Leiomyoma
-lesions? |
sarcoma = single lesion (with necrosis mitotic activity)
myoma = multiple lesions |
|
Leiomyomas aka?
|
(fibroids)
|
|
Leiomyomas
-define path -incidence -presentation |
smooth muscle tumor of the uterine wall
-25% of ALL reproductive age women; higher in African American -clinical feature = asymptomatic |
|
Leiomyomas
-gross and histo |
multiple Whorled smooth muscle bundles ~ myometrium
-firm, round, gray-white masses. range in size, small to large |
|
Leiomyoma
-clinical features |
Asymptomatic,
Hormonally responsive (related to estrogen exposure) -multiple well defined white whorled masses -BENIGN |
|
Leiomyoma -
|
leio means smooth
myoma means muscle |
|
age of Leiomyoma vs Leiomyosarcoma?
|
Leiomyoma - premenopausal women (caused by estrogen)
Leiomyosarcoma- post menopausal |
|
Leiomyosarcoma
-gross and histo features? |
single lesion with necros, inc mitosis,and cellular atypia
|
|
Leiomyosarcoma
-gross and histo features? |
single lesion with necros, inc mitosis,and cellular atypia
|